Short‐term cost‐utility of degludec versus glargine U100...

  • Main
  • 2019 / 03
  • Short‐term cost‐utility of degludec versus glargine U100...

Short‐term cost‐utility of degludec versus glargine U100 for patients with type 2 diabetes at high risk of hypoglycaemia and cardiovascular events – a Canadian setting (DEVOTE 9)

Pollock, Richard F, Heller, Simon, Pieber, Thomas R, Woo, Vincent, Gundgaard, Jens, Hallén, Nino, Luckevich, Maria, Tutkunkardas, Deniz, Zinman, Bernard
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Diabetes, Obesity and Metabolism
DOI:
10.1111/dom.13730
Date:
March, 2019
File:
PDF, 835 KB
english, 2019
Conversion to is in progress
Conversion to is failed